These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 32634262)
1. PTEN and ERG expression in MRI-ultrasound guided fusion biopsy correlated with radical prostatectomy findings in men with prostate cancer. Erickson AM; Lokman U; Lahdensuo K; Tornberg S; Visapaa H; Bergroth R; Santti H; Petas A; Rannikko AS; Mirtti T Prostate; 2020 Sep; 80(13):1118-1127. PubMed ID: 32634262 [TBL] [Abstract][Full Text] [Related]
2. PTEN Loss but Not ERG Expression in Diagnostic Biopsies Is Associated with Increased Risk of Progression and Adverse Surgical Findings in Men with Prostate Cancer on Active Surveillance. Lokman U; Erickson AM; Vasarainen H; Rannikko AS; Mirtti T Eur Urol Focus; 2018 Dec; 4(6):867-873. PubMed ID: 28753869 [TBL] [Abstract][Full Text] [Related]
3. Postoperative change in Gleason score of prostate cancer in fusion targeted biopsy: a matched pair analysis. Apfelbeck M; Tritschler S; Clevert DA; Buchner A; Chaloupka M; Kretschmer A; Herlemann A; Stief C; Schlenker B Scand J Urol; 2021 Feb; 55(1):27-32. PubMed ID: 33380254 [TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients. Baco E; Ukimura O; Rud E; Vlatkovic L; Svindland A; Aron M; Palmer S; Matsugasumi T; Marien A; Bernhard JC; Rewcastle JC; Eggesbø HB; Gill IS Eur Urol; 2015 Apr; 67(4):787-94. PubMed ID: 25240973 [TBL] [Abstract][Full Text] [Related]
6. PTEN and ERG detection in multiparametric magnetic resonance imaging/ultrasound fusion targeted prostate biopsy compared to systematic biopsy. Baumgartner E; Del Carmen Rodriguez Pena M; Eich ML; Porter KK; Nix JW; Rais-Bahrami S; Gordetsky J Hum Pathol; 2019 Aug; 90():20-26. PubMed ID: 31075299 [TBL] [Abstract][Full Text] [Related]
7. Multiparametric-Magnetic Resonance/Ultrasound Fusion Targeted Prostate Biopsy Improves Agreement Between Biopsy and Radical Prostatectomy Gleason Score. Porpiglia F; DE Luca S; Passera R; Manfredi M; Mele F; Bollito E; DE Pascale A; Cossu M; Aimar R; Veltri A Anticancer Res; 2016 Sep; 36(9):4833-9. PubMed ID: 27630337 [TBL] [Abstract][Full Text] [Related]
8. Targeted Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy for Quantitative Gleason 4 Grading Prediction in Radical Prostatectomy Specimens: Implications for Active Surveillance Candidate Selection. Kachanov M; Budäus L; Beyersdorff D; Karakiewicz PI; Tian Z; Falkenbach F; Tilki D; Maurer T; Sauter G; Graefen M; Leyh-Bannurah SR Eur Urol Focus; 2023 Mar; 9(2):303-308. PubMed ID: 36184537 [TBL] [Abstract][Full Text] [Related]
9. The Highest Grade Group Does Not Drive the Risk of Recurrence when Systematic and Multiparametric Magnetic Resonance Imaging (MRI)-targeted Biopsies are Discordant: Preliminary Findings Using Radical Prostatectomy Pathology as a Surrogate for MRI-targeted Biopsy Grade. Scuderi S; Pellegrino F; Tin A; Beech BB; Gandaglia G; Stabile A; Eastham JA; Montorsi F; Briganti A; Vickers AJ Eur Urol Focus; 2024 May; 10(3):486-488. PubMed ID: 37739916 [TBL] [Abstract][Full Text] [Related]
10. Multiparametric MRI/ultrasound fusion-guided biopsy decreases detection of indolent cancer in African-American men. Kongnyuy M; Siddiqui MM; George AK; Muthigi A; Sidana A; Maruf M; Turkbey B; Choyke PL; Wood BJ; Pinto PA Prostate Cancer Prostatic Dis; 2017 Sep; 20(3):348-351. PubMed ID: 28440325 [TBL] [Abstract][Full Text] [Related]
11. Associations of PTEN and ERG with Magnetic Resonance Imaging Visibility and Assessment of Non-organ-confined Pathology and Biochemical Recurrence After Radical Prostatectomy. Eineluoto JT; Sandeman K; Pohjonen J; Sopyllo K; Nordling S; Stürenberg C; Malén A; Kilpeläinen TP; Santti H; Petas A; Matikainen M; Pellinen T; Järvinen P; Kenttämies A; Rannikko A; Mirtti T Eur Urol Focus; 2021 Nov; 7(6):1316-1323. PubMed ID: 32620540 [TBL] [Abstract][Full Text] [Related]
12. The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy. Maruf M; Fascelli M; George AK; Siddiqui MM; Kongnyuy M; DiBianco JM; Muthigi A; Valayil S; Sidana A; Frye TP; Kilchevsky A; Choyke PL; Turkbey B; Wood BJ; Pinto PA Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):179-185. PubMed ID: 28220802 [TBL] [Abstract][Full Text] [Related]
13. Transcriptome Wide Analysis of Magnetic Resonance Imaging-targeted Biopsy and Matching Surgical Specimens from High-risk Prostate Cancer Patients Treated with Radical Prostatectomy: The Target Must Be Hit. Radtke JP; Takhar M; Bonekamp D; Kesch C; Erho N; du Plessis M; Buerki C; Ong K; Davicioni E; Hohenfellner M; Hadaschik BA Eur Urol Focus; 2018 Jul; 4(4):540-546. PubMed ID: 28753844 [TBL] [Abstract][Full Text] [Related]
14. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen. Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346 [TBL] [Abstract][Full Text] [Related]
15. Gleason Grade Group Concordance between Systematic Template Combining Magnetic Resonance Imaging Fusion Targeted Biopsy and Radical Prostatectomy Specimens: A Comparison of Transperineal and Transrectal Approaches. Wu S; Feldman AS; Kim MM; Lin SX; Cornejo KM; Harisinghani MG; Dahl DM; Wu CL Urology; 2023 May; 175():151-156. PubMed ID: 36828261 [TBL] [Abstract][Full Text] [Related]
16. A Comparison of Cancer Detection Rates Between Template Systematic Biopsies Obtained Using Magnetic Resonance Imaging-Ultrasound Fusion Machine and Freehand Transrectal Ultrasound-Guided Systematic Biopsies. Hoge C; Maynor S; Guan T; Naffouje R; Rao M; Verma S; Sidana A J Endourol; 2020 Oct; 34(10):1095-1098. PubMed ID: 32631097 [No Abstract] [Full Text] [Related]
17. Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy. Mannaerts CK; Gayet M; Verbeek JF; Engelbrecht MRW; Savci-Heijink CD; Jager GJ; Gielens MPM; van der Linden H; Beerlage HP; de Reijke TM; Wijkstra H; Roobol MJ Eur Urol Oncol; 2018 Jun; 1(2):109-117. PubMed ID: 31100233 [TBL] [Abstract][Full Text] [Related]
18. Adverse Pathology after Radical Prostatectomy of Patients Eligible for Active Surveillance-A Summary 7 Years after Introducing mpMRI-Guided Biopsy in a Real-World Setting. Ebner B; Apfelbeck M; Pyrgidis N; Nellessen T; Ledderose S; Pfitzinger PL; Volz Y; Berg E; Enzinger B; Rodler S; Atzler M; Ivanova T; Clevert DA; Stief CG; Chaloupka M Bioengineering (Basel); 2023 Feb; 10(2):. PubMed ID: 36829741 [TBL] [Abstract][Full Text] [Related]
19. Detection of Gleason 6 prostate cancer in patients with clinically significant prostate cancer on multiparametric magnetic resonance imaging. Chaloupka M; Bischoff R; Pfitzinger P; Lellig E; Ledderose S; Buchner A; Schlenker B; Stief C; Clevert DA; Apfelbeck M Clin Hemorheol Microcirc; 2019; 73(1):105-111. PubMed ID: 31561351 [TBL] [Abstract][Full Text] [Related]
20. Comparison of TRUS and combined MRI-targeted plus systematic prostate biopsy for the concordance between biopsy and radical prostatectomy pathology. Aslan G; Çelik S; Sözen S; Akdoğan B; İzol V; Yücel Bilen C; Sahin B; Türkeri L; Int J Clin Pract; 2021 Mar; 75(3):e13797. PubMed ID: 33113261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]